Nuclear Medicine Imaging of the Pediatric Musculoskeletal System

被引:11
作者
Shammas, Amer [1 ,2 ]
机构
[1] Univ Toronto, Div Nucl Med, Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Med Imaging, Toronto, ON M5G 1X8, Canada
关键词
Children; musculoskeletal; bone; scintigraphy; PET/CT; FDG; LANGERHANS CELL HISTIOCYTOSIS; CALVE-PERTHES-DISEASE; BROWN ADIPOSE-TISSUE; PRIMARY BONE-TUMORS; FDG-PET; F-18-FDG PET/CT; TOMOGRAPHY/COMPUTED TOMOGRAPHY; CONVENTIONAL RADIOGRAPHY; SCINTIGRAPHIC FINDINGS; SKELETAL SCINTIGRAPHY;
D O I
10.1055/s-0029-1237687
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Bone scintigraphy is a common pediatric nuclear medicine procedure and plays a significant role in the diagnosis of skeletal infection, trauma, and benign and malignant bone tumors. There is a complementary role for bone scintigraphy in the assessment of a child with suspected nonaccidental injury. High-quality images require careful attention to technique and positioning in children. Additional techniques such as magnification and single-photon emission computed tomography (SPECT) can be used for special indications and localization. Combined functional and anatomic imaging using SPECT/computed tomography (CT) imaging systems can improve diagnostic accuracy. Positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (FDG) is being applied with increasing frequency in the evaluation of children with malignancy. To interpret F-18-FDG PET appropriately, it is essential to know the normal physiological distribution. Using combined F-18-FDG PET/CT improves specificity and localization. This article reviews the common indications for bone scintigraphy and F-18-FDG PET/CT in benign and malignant pediatric musculoskeletal disease.
引用
收藏
页码:159 / 180
页数:22
相关论文
共 82 条
  • [1] Anderson MW, 1996, RADIOLOGY, V199, P1
  • [2] FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions
    Aoki, J
    Watanabe, H
    Shinozaki, T
    Takagishi, K
    Ishijima, H
    Oya, N
    Sato, N
    Inoue, T
    Endo, K
    [J]. RADIOLOGY, 2001, 219 (03) : 774 - 777
  • [3] Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma
    Arush, M. Weyl Ben
    Israel, O.
    Postovsky, S.
    Militianu, D.
    Meller, I.
    Zaidman, I.
    Sapir, A. Even
    Bar-Shalom, R.
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (07) : 901 - 905
  • [4] Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement
    Azouz, EM
    Saigal, G
    Rodriguez, MM
    Podda, A
    [J]. PEDIATRIC RADIOLOGY, 2005, 35 (02) : 103 - 115
  • [5] Guidelines for the use of PET-CT in children
    Barrington, Sally F.
    Begent, Joanna
    Lyunch, Thomas
    Schleyer, Paul
    Biassoni, Lorenzo
    Ramsden, William
    Kane, Thomas
    Stoneham, Sara
    Brooks, Margaret
    Hain, Sharon F.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (05) : 418 - 424
  • [6] Barrington SF, 1996, J NUCL MED, V37, P1127
  • [7] Bernard EJ, 1998, J NUCL MED, V39, P1983
  • [8] Conversion of FDG PET Activity of Fibrous Dysplasia of the Skull Late in Life Mimicking Metastatic Disease
    Bonekamp, David
    Jacene, Heather
    Bartelf, Detlef
    Aygun, Nafi
    [J]. CLINICAL NUCLEAR MEDICINE, 2008, 33 (12) : 909 - 911
  • [9] Brenner W, 2003, J NUCL MED, V44, P930
  • [10] Brix G, 2005, J NUCL MED, V46, P608